To celebrate its 50th anniversary, the IASLC (International Association for the Study of Lung Cancer) invites you to the World Conference on Lung Cancer 2024 (WCLC), the world's largest international meeting of experts in the field of lung cancer, in San Diego (USA) from September 7 to 10, 2024. MeVis Medical Solutions AG is pleased to present Veolity - its all-in-one solution for lung cancer diagnostics.
Veolity has been successfully deployed in over 100 lung cancer screening sites nationwide in the United States since 2014, but it is also popular in many other regions around the world, such as Europe, Canada, and Australia.
Radiologists benefit from AI-based CAD for better lung nodule detection, volumetric measurements, automated growth assessment, guideline compliant reporting (e.g. Lung-RADS) and an automated workflow that can reduce reading times compared to a PACS viewer.
In addition to this valuable workflow support in medical diagnostics, Veolity can be integrated into an existing patient management system or, alternatively, into a new PMS of your choice while maintaining a consistent high quality and efficiency with standardized procedures for screening protocol, reading, reporting, and follow-up. MeVis collaborates with international specialists who develop and offer patient management systems that cover all pre- and post- screening processing steps.
Would you like to know more about Veolity and its integration into a patient management system? Please visit us at our booth no. 1021 at WCLC 2024. We look forward to meeting you in person!
Venue:
San Diego Convention Center
111 West Harbor Drive
San Diego, CA 92101
USA